Improved Function and Myocardial Repair of Infarcted Heart by Intracoronary Injection of Mesenchymal Stem Cell-Derived Growth Factors
Ba-Khoi Nguyen(Centre Hospitalier de l’Université de Montréal), Nicolas Noiseux(Centre Hospitalier de l’Université de Montréal), François Harel(Montreal Heart Institute), Louis‐Mathieu Stevens(Montreal Heart Institute), Samer Mansour(Centre Hospitalier de l’Université de Montréal), Jean-François Tanguay(Montreal Heart Institute), Simon Maltais(Intermountain Healthcare), Jean‐Claude Tardif(Montreal Heart Institute), Mélanie Borie(Centre Hospitalier de l’Université de Montréal), Louis P. Perrault(Montreal Heart Institute)
Cited by 109
Related Papers
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
|New England Journal of Medicine|2015|2.3k
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
|New England Journal of Medicine|2012|2k
Guidelines for Perioperative Care in Cardiac Surgery
|JAMA Surgery|2019|1.2k